UPDATE: Agile Initiates Phase 3 SECURE Study for Twirla
September 16, 2014 at 08:00 AM EDT
Agile Therapeutics, Inc., (Nasdaq: AGRX) a women's health specialty pharmaceutical company focused on the development and ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.